The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

In a major positive step for global respiratory health, Member States at the 78th World Health Assembly (WHA), held May 19–27 ...

Understanding the differences between colds, flu, and RSV can help in identifying the illness you're dealing with, the ...

The National Oceanic and Atmospheric Administration says people should start exercising “caution” when the heat index reaches ...

The sound of rain may feel romantic to some, but for parents? It’s a seasonal alarm bell. Not just puddles and power cuts, an annual wave of infections that hit kids the hardest.

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.

The main pharmacological interventions for palliation of breathlessness would be opioids, ie, oromorph and benzodiazepines ...

In this week’s edition of InnovationRx, we look at the health impact of the Republican spending bill, a startup that built a hospital in India to test its AI software, the impact of the vaccine panel ...

Its second mRNA vaccine, for respiratory syncytial virus (RSV), is already on the market ... Moderna has various cancer vaccines in the clinic, including for lung and bladder cancer. They could be ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...